Innovative EyewearLUCY +0.11%56 EBITDA Margin % is -302.71% as of Mar. 2026. GuruFocus rates LUCY with a GF Score™ of 56/100 and a GF Value™ of $1.82 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 816 Medical Devices & Instruments companies, Innovative Eyewear ranks worse than 89.71% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Innovative Eyewear's EBITDA for the
three
months ended in Mar. 2026 was $-2.34 Mil. Innovative Eyewear's Revenue for the
three
months ended in Mar. 2026 was $0.77 Mil. Therefore, Innovative Eyewear's EBITDA margin for the quarter that ended in Mar. 2026 was -302.71%.
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Innovative Eyewear EBITDA Margin % Related Terms
Innovative Eyewear EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Innovative Eyewear's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LUCY vs CUPR, MHUAF, NXGL: EBITDA Margin % Comparison
For the Medical Instruments & Supplies subindustry, Innovative Eyewear's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Innovative Eyewear EBITDA Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Innovative Eyewear's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Innovative Eyewear's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Innovative Eyewear (LUCY) has a EBITDA Margin % of -302.71% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Innovative Eyewear and its competitors. According to the industry distribution chart, Innovative Eyewear ranks #732 out of 816 companies in the Medical Devices & Instruments industry, placing it in the top 89.7%.
Is Innovative Eyewear's EBITDA Margin % too high?
Innovative Eyewear's current EBITDA Margin % is -302.71%. Based on the distribution chart, Innovative Eyewear ranks #732 out of 816 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Innovative Eyewear has a GF Score™ of 56/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Innovative Eyewear's EBITDA Margin % compare to CUPR and MHUAF?
According to the Medical Devices & Instruments industry distribution chart, Innovative Eyewear ranks #732 out of 816 companies for EBITDA Margin %. This places Innovative Eyewear in the lower half of its industry. The industry median EBITDA Margin % is 7.48. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Medical Devices & Instruments company?
The median EBITDA Margin % among Medical Devices & Instruments companies is 7.48, based on 816 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Innovative Eyewear and its competitors. For the Medical Devices & Instruments industry, the median EBITDA Margin % is 7.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Innovative Eyewear's current EBITDA Margin % is -302.71%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Innovative Eyewear stock overvalued right now?
Based on GuruFocus' analysis, Innovative Eyewear (LUCY) is currently considered Possible Value Trap. The stock's GF Value™ is $1.82, compared to a current price of $0.74 — trading 59.3% below its estimated fair value. The current EBITDA Margin % is -302.71%. Innovative Eyewear's overall GF Score™ is 56/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Innovative Eyewear (LUCY), the current EBITDA Margin % is -302.71% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Innovative Eyewear (LUCY) Overvalued in 2026?
Based on GuruFocus' analysis, Innovative Eyewear stock appears to be undervalued.
The current stock price of $0.74 is trading 59.3% below its estimated GF Value™ of $1.82.
GuruFocus considers Innovative Eyewear to be Possible Value Trap.
Key valuation signals for LUCY:
EBITDA Margin %: -302.71%
GF Value™: $1.82 vs. price of $0.74 (59.3% below fair value)
No single metric tells the full story. See the LUCY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Innovative Eyewear Inc is engaged in developing and selling eyeglasses and sunglasses, which are designed to allow customers to remain connected to their digital lives, while also offering prescription eyewear and sun protection. Its products include Lucyd Lyte, Nautica, Eddie Bauer, Lucyd Armor line, and Reebok. The firm derive substantially all of its revenue from the sale of smart glasses and custom lenses.
56GF Score
Get the complete analysis for LUCY
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LUCY has been successfully added to your 
